LFCR Stock Price, Chart, Stats & News
Lifecore Biomedical, Inc. (LFCR) does not currently pay a dividend.
LFCR chart
Fundamentals
Gross margin | 32.30% |
Operating margin | -3.01% |
Pretax margin | -22.78% |
Net margin | -23.03% |
Effective tax rate | -1.08% |
ROA | -14.59% |
ROE | -182.11% |
D/E | 4.23x |
Interest coverage ratio | -0.21x |
LFCR valuation
P/E | – |
P/S | 0.93x |
P/B | 4.03x |
P/CF | 9.88x |
P/FCF | 52.19x |
P/OCF | 9.88x |
PEG | -0.04x |
EV multiple | -5.03x |
About
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications.
Similar securities
Based on sector and market capitalization
